JP2025508606A5 - - Google Patents

Info

Publication number
JP2025508606A5
JP2025508606A5 JP2024572512A JP2024572512A JP2025508606A5 JP 2025508606 A5 JP2025508606 A5 JP 2025508606A5 JP 2024572512 A JP2024572512 A JP 2024572512A JP 2024572512 A JP2024572512 A JP 2024572512A JP 2025508606 A5 JP2025508606 A5 JP 2025508606A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
cdr2
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024572512A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025508606A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/074767 external-priority patent/WO2023160376A1/en
Publication of JP2025508606A publication Critical patent/JP2025508606A/ja
Publication of JP2025508606A5 publication Critical patent/JP2025508606A5/ja
Pending legal-status Critical Current

Links

JP2024572512A 2022-02-25 2023-02-07 ヒトb7-h3に対する抗体及びその変異体 Pending JP2025508606A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2022/078008 2022-02-25
CN2022078008 2022-02-25
PCT/CN2023/074767 WO2023160376A1 (en) 2022-02-25 2023-02-07 Antibodies and variants thereof against human b7-h3

Publications (2)

Publication Number Publication Date
JP2025508606A JP2025508606A (ja) 2025-03-26
JP2025508606A5 true JP2025508606A5 (cg-RX-API-DMAC7.html) 2026-02-18

Family

ID=86447199

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024572512A Pending JP2025508606A (ja) 2022-02-25 2023-02-07 ヒトb7-h3に対する抗体及びその変異体

Country Status (7)

Country Link
US (1) US20250188167A1 (cg-RX-API-DMAC7.html)
EP (1) EP4482874A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025508606A (cg-RX-API-DMAC7.html)
KR (1) KR20240151787A (cg-RX-API-DMAC7.html)
CN (3) CN116903743B (cg-RX-API-DMAC7.html)
AU (1) AU2023226435A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023160376A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026063874A1 (en) * 2024-09-20 2026-03-26 Hummingbird Bioscience Pte. Ltd. B7-h3 antigen-binding molecules
WO2026062200A1 (en) * 2024-09-20 2026-03-26 Hummingbird Bioscience Pte. Ltd. B7-h3 antigen-binding molecules

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2542256T3 (da) * 2010-03-04 2019-08-26 Macrogenics Inc Antistoffer reagerende med b7-h3, immunologisk aktive fragmenter deraf og anvendelser deraf
AU2014268298B2 (en) * 2013-05-24 2019-01-17 Medlmmune, Llc Anti-B7-H5 antibodies and their uses
CN109069633A (zh) * 2016-04-15 2018-12-21 宏观基因有限公司 新颖的b7-h3-结合分子、其抗体药物缀合物及其使用方法
CN109641962A (zh) * 2016-06-08 2019-04-16 艾伯维公司 抗b7-h3抗体和抗体药物偶联物
RS61828B1 (sr) * 2016-06-08 2021-06-30 Abbvie Inc Anti-b7-h3 antitela i antitelske konjugacije lekova
JP2019526529A (ja) * 2016-06-08 2019-09-19 アッヴィ・インコーポレイテッド 抗b7−h3抗体及び抗体薬物コンジュゲート
AR110607A1 (es) * 2016-06-08 2019-04-17 Abbvie Inc Anticuerpos anti-b7-h3 y conjugados de fármaco y anticuerpos
CN109843927B (zh) * 2017-03-06 2022-06-21 江苏恒瑞医药股份有限公司 抗b7-h3抗体、其抗原结合片段及其医药用途
CA3056474A1 (en) * 2017-03-31 2018-10-04 Jiangsu Hengrui Medicine Co., Ltd. B7-h3 antibody, antigen-binding fragment thereof and medical use thereof
WO2019225787A1 (ko) * 2018-05-24 2019-11-28 에이비엘바이오 주식회사 항-b7-h3 항체 및 그 용도
EP3883970A4 (en) * 2018-11-22 2022-03-30 Suzhou Kanova Biopharmaceutical Co., Ltd. ANTI-B7-H3 ANTIBODIES
EP4039702A1 (en) * 2019-09-16 2022-08-10 Nanjing Sanhome Pharmaceutical Co., Ltd. Anti-b7-h3 antibody and application thereof
CN113527487A (zh) * 2020-04-22 2021-10-22 复星凯特生物科技有限公司 抗人b7-h3的单克隆抗体及其应用
CN111662384B (zh) * 2020-06-30 2021-04-09 广州百暨基因科技有限公司 抗b7h3抗体及其应用
CN111944050B (zh) * 2020-08-19 2022-05-13 苏州普乐康医药科技有限公司 一种抗b7-h3抗体及其应用
CN113402610B (zh) * 2021-06-09 2023-02-24 英诺湖医药(杭州)有限公司 一组b7h3单克隆抗体及其医药用途

Similar Documents

Publication Publication Date Title
JP2023509448A5 (cg-RX-API-DMAC7.html)
JP2022533538A5 (cg-RX-API-DMAC7.html)
JP2017535257A5 (cg-RX-API-DMAC7.html)
JP2023540526A5 (cg-RX-API-DMAC7.html)
JP2026041845A5 (cg-RX-API-DMAC7.html)
JP2021520825A5 (cg-RX-API-DMAC7.html)
JP2021516951A5 (cg-RX-API-DMAC7.html)
JP2015509947A5 (cg-RX-API-DMAC7.html)
JP2017500028A5 (cg-RX-API-DMAC7.html)
JP2024001073A5 (cg-RX-API-DMAC7.html)
JP2020522280A5 (cg-RX-API-DMAC7.html)
JP2024534265A5 (cg-RX-API-DMAC7.html)
JP2023089245A5 (cg-RX-API-DMAC7.html)
JP2024016024A5 (cg-RX-API-DMAC7.html)
JP2024518776A5 (cg-RX-API-DMAC7.html)
JP2021511387A5 (cg-RX-API-DMAC7.html)
JP2024515560A5 (cg-RX-API-DMAC7.html)
JP2023517794A5 (cg-RX-API-DMAC7.html)
JP2025513745A5 (cg-RX-API-DMAC7.html)
JP2022513729A5 (cg-RX-API-DMAC7.html)
JP2023536631A5 (cg-RX-API-DMAC7.html)
JP2023517754A5 (cg-RX-API-DMAC7.html)
CN111712521A (zh) Cd38蛋白抗体及其应用
JP2025503229A5 (cg-RX-API-DMAC7.html)
JP2024517953A5 (cg-RX-API-DMAC7.html)